FDA Approves Marketing Of Consumer Genetic Tests For Some Conditions
The company 23andMe is now allowed to market tests that assess genetic risks for 10 health conditions, including Parkinson's disease and late-onset Alzheimer's disease.
Read more on NPR
Health Care
April 8, 2017 at 12:40AM
Blog Beauty 24/7
Không có nhận xét nào:
Đăng nhận xét